|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,023.00 GBX | +0.40% |
|
+2.10% | +10.78% |
| 01:33pm | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| 10:04am | Novartis to Buy Myricx Bio for Up to $1.5 Billion -- Update | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.40% | +2.10% | +5.65% | -3.57% | +10.78% | +44.83% | +51.19% | +12.74% | -2.13% | 107B | ||
| +1.86% | +0.48% | +7.29% | +29.75% | +12.96% | +55.50% | +160.66% | +418.85% | +1,424.25% | 1,082B | ||
| +3.57% | +3.29% | +13.00% | +8.23% | +27.10% | +68.60% | +61.56% | +55.66% | +115.13% | 633B | ||
| +3.99% | +3.05% | +14.89% | +25.01% | +14.26% | +37.93% | +89.70% | +126.68% | +321.62% | 461B | ||
| -1.32% | +1.37% | +4.13% | +7.11% | +3.78% | +31.00% | +23.05% | -2.78% | +34.89% | 338B | ||
| -1.43% | -0.44% | +3.18% | -4.83% | +3.23% | +39.31% | +37.83% | +63.23% | +212.69% | 299B | ||
| -0.36% | +0.90% | +8.52% | +6.29% | +16.19% | +30.46% | +45.25% | +50.61% | +59.97% | 291B | ||
| -0.87% | +2.70% | +18.90% | +37.56% | -0.57% | -26.70% | -40.23% | +21.31% | +80.12% | 222B | ||
| +3.55% | +4.41% | +7.03% | +7.53% | +14.31% | +25.45% | +65.64% | +50.44% | +142.53% | 202B | ||
| +4.21% | +2.65% | +1.63% | -6.04% | +6.95% | +17.47% | +69.95% | +89.42% | +56.48% | 163B | ||
| +1.84% | +0.12% | -6.61% | -14.12% | -2.33% | -4.18% | -33.30% | -38.79% | -32.09% | 139B | ||
| +6.03% | +7.47% | +18.17% | +20.36% | +16.47% | +14.89% | +51.60% | +163.31% | +510.38% | 134B | ||
| +2.99% | +1.06% | +1.50% | -2.47% | +7.77% | +23.89% | -10.20% | -13.17% | -21.21% | 119B | ||
| +0.99% | +1.40% | -0.14% | -4.91% | -7.45% | -7.13% | -19.44% | -11.77% | +3.87% | 104B | ||
| -1.32% | -0.44% | +1.02% | -14.94% | -8.52% | +5.62% | +94.31% | +76.27% | +517.27% | 77.98B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| -1.03% | +14.49% | +47.66% | +34.20% | +42.39% | +101.53% | +8.39% | +3.99% | -40.30% | 59.97B | ||
| +1.79% | +11.88% | +15.65% | -3.42% | -8.59% | +2.23% | +10.69% | -13.50% | +261.88% | 53.01B | ||
| +2.95% | +6.59% | +9.25% | -4.12% | +14.11% | +25.05% | +22.79% | +49.19% | +25.84% | 52.5B | ||
| -0.16% | +4.25% | +9.73% | -1.63% | -3.09% | -2.18% | +16.52% | - | - | 42.89B | ||
| Average | +0.31% | +4.56% | +9.50% | +6.11% | +8.41% | +25.45% | +37.16% | +61.20% | +203.96% | 232.25B | |
| Weighted average by Cap. | -0.31% | +5.25% | +8.88% | +13.23% | +11.75% | +37.19% | +69.24% | +139.35% | +446.50% |
- Stock Market
- Stocks
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
















